Literature DB >> 15814194

A family-based association study of schizophrenia with polymorphisms at three candidate genes.

Shiwei Duan1, Rui Gao, Qinghe Xing, Jing Du, Zhuangjun Liu, Qi Chen, Hongsheng Wang, Guoyin Feng, Lin He.   

Abstract

Clinical researches have shown that there is a genetic contribution to the pathogenesis of schizophrenia. Recent studies have suggested that three genes neuropeptide Y (NPY), phosphoinositide-3-kinase class 3 (PIK3C3) and 14-3-3 eta chain gene (YWHAH) are probably associated with schizophrenia. To replicate these findings, we carried out a family-based study on a sample of 235 trios. Our results suggest that the polymorphisms at the NPY and YWHAH genes are unlikely to be linked with genetic susceptibility to schizophrenia. However, we found significant evidence of preferential transmission of the -432C allele of the PIK3C3 gene in the entire trios (Z=2.91, d.f.=1, P=0.0036) and the male probands trios (Z=2.66, d.f.=1, P=0.0079).

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15814194     DOI: 10.1016/j.neulet.2004.12.040

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  21 in total

1.  Human NPY promoter variation rs16147:T>C as a moderator of prefrontal NPY gene expression and negative affect.

Authors:  Wolfgang H Sommer; Jessica Lidström; Hui Sun; Derek Passer; Robert Eskay; Stephen C J Parker; Stephanie H Witt; Ulrich S Zimmermann; Vanessa Nieratschker; Marcella Rietschel; Elliott H Margulies; Miklós Palkovits; Manfred Laucht; Markus Heilig
Journal:  Hum Mutat       Date:  2010-08       Impact factor: 4.878

2.  Transmission disequilibrium test provides evidence of association between promoter polymorphisms in 22q11 gene DGCR14 and schizophrenia.

Authors:  H Wang; S Duan; J Du; X Li; Y Xu; Z Zhang; Y Wang; G Huang; G Feng; L He
Journal:  J Neural Transm (Vienna)       Date:  2006-01-25       Impact factor: 3.575

Review 3.  Antipsychotic drug mechanisms: links between therapeutic effects, metabolic side effects and the insulin signaling pathway.

Authors:  R R Girgis; J A Javitch; J A Lieberman
Journal:  Mol Psychiatry       Date:  2008-04-15       Impact factor: 15.992

Review 4.  Co-shared genetics and possible risk gene pathway partially explain the comorbidity of schizophrenia, major depressive disorder, type 2 diabetes, and metabolic syndrome.

Authors:  Teodor T Postolache; Laura Del Bosque-Plata; Serge Jabbour; Michael Vergare; Rongling Wu; Claudia Gragnoli
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2019-02-06       Impact factor: 3.568

5.  No effect of adjunctive, repeated dose intranasal insulin treatment on body metabolism in patients with schizophrenia.

Authors:  Jie Li; Xue Li; Emily Liu; Paul Copeland; Oliver Freudenreich; Donald C Goff; David C Henderson; Xueqin Song; Xiaoduo Fan
Journal:  Schizophr Res       Date:  2013-02-21       Impact factor: 4.939

Review 6.  Signaling pathways in schizophrenia: emerging targets and therapeutic strategies.

Authors:  Caline S Karam; Jacob S Ballon; Nancy M Bivens; Zachary Freyberg; Ragy R Girgis; José E Lizardi-Ortiz; Sander Markx; Jeffrey A Lieberman; Jonathan A Javitch
Journal:  Trends Pharmacol Sci       Date:  2010-06-25       Impact factor: 14.819

7.  No effect of adjunctive, repeated-dose intranasal insulin treatment on psychopathology and cognition in patients with schizophrenia.

Authors:  Xiaoduo Fan; Emily Liu; Oliver Freudenreich; Paul Copeland; Douglas Hayden; Musie Ghebremichael; Bruce Cohen; Dost Ongur; Donald C Goff; David C Henderson
Journal:  J Clin Psychopharmacol       Date:  2013-04       Impact factor: 3.153

8.  Promoter variant of PIK3C3 is associated with autoimmunity against Ro and Sm epitopes in African-American lupus patients.

Authors:  Silvia N Kariuki; Beverly S Franek; Rachel A Mikolaitis; Tammy O Utset; Meenakshi Jolly; Andrew D Skol; Timothy B Niewold
Journal:  J Biomed Biotechnol       Date:  2010-07-04

Review 9.  Target identification for CNS diseases by transcriptional profiling.

Authors:  C Anthony Altar; Marquis P Vawter; Stephen D Ginsberg
Journal:  Neuropsychopharmacology       Date:  2008-10-15       Impact factor: 7.853

10.  Allelic variation in the NPY gene in 14 Indian populations.

Authors:  L V K S Bhaskar; K Thangaraj; Anish M Shah; G Pardhasaradhi; K Praveen Kumar; A G Reddy; A Papa Rao; C J Mulligan; Lalji Singh; V R Rao
Journal:  J Hum Genet       Date:  2007-06-07       Impact factor: 3.172

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.